Frontiers of Nanobiotechnology: Microfluidic Devices and Biomems for the Future

This book provides a comprehensive overview of microfluidic-assisted devices and bioMEMS, covering their fundamental principles, manufacturing processes, and biomedical applications. It explores the design, fabrication, and integration of microfluidic devices and MEMS, emphasizing their role in microscale physics and biomedical engineering. Key topics include micropumps, biosensors, and organ-on-a-chip systems, with applications in drug discovery, disease diagnosis, and tissue engineering. The book also discusses recent advances in the field, particularly the integration of biosensors with microfluidic systems, highlighting their growing impact on biomedical research and healthcare innovations.

Dr. Seyed Morteza Naghib received his Ph.D. in biomedical engineering from Tehran Polytechnique (2014) and M.ASc. (2010) and B.ASc. (2009) degrees from Amirkabir University of Technology both in biomedical engineering (biomaterials). His research interests are in the areas of tissue engineering, medical nanotechnology, nanobiomaterials, nanocarriers, and nanobiosensors. He also published 3 books in the field entitled ＂Localized Micro/Nanocarriers for Programmed and On-Demand Controlled Drug Release＂, ＂Electrochemical Biosensors in Practice: Materials and Methods＂, and ＂Green plant extract-based synthesis of multifunctional nanoparticles and their biological activities＂.

Yasaman Rezaeian graduated in Nanotechnology Engineering-Nanomaterials from Iran University of Science and Technology and in Physics from Ferdowsi University of Mashhad. During her studies, she ranked second among the top three students in her faculty. Since 2021, she has been working as a research assistant at Motamed Cancer Institute, investigating novel nanomaterials and treatments for breast cancers, especially working on drug carriers for controlled release. Her research includes the synthesis of drug delivery carriers for controlled release to increase the precision and effectiveness of treatment, and she has spent nearly two years advancing cancer research at the institute. She is recognized as a talented young researcher in these fields.